CHEMCON.NS
Chemcon Speciality Chemicals Limited [CHEMCON.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CHEMCON.NS Stock Summary
Top 10 Correlated ETFs
CHEMCON.NS
Top 10 Correlated Stocks
CHEMCON.NS
In the News
CHEMCON.NS Financial details
Company Rating
-
Market Cap
10.19B
Income
336.75M
Revenue
3.1B
Book val./share
127.98
Cash/share
39.08
Dividend
-
Dividend %
-
Employees
204
Optionable
No
Shortable
Yes
Earnings
01 Feb 2024
P/E
30.28
Forward P/E
-
PEG
-6.52
P/S
3.29
P/B
2.17
P/C
7.12
P/FCF
-
Quick Ratio
3.48
Current Ratio
5.01
Debt / Equity
0.08
LT Debt / Equity
0
-
-
EPS (TTM)
9.18
EPS next Y
-
EPS next Q
-
EPS this Y
-12.2%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.06%
Revenue last 5Y
0.01%
Revenue Q/Q
-5.21%
EPS Q/Q
0.62%
-
-
-
-
SMA20
1.72%
SMA50
-5.84%
SMA100
0.08%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
15%
ROC
0.09%
Gross Margin
30%
Oper. Margin
14%
Profit Margin
11%
Payout
-
Shs Outstand
36.63M
Shs Float
9.36M
-
-
-
-
Target Price
-
52W Range
221.0-319.45
52W High
-12.79%
52W Low
+25.88%
RSI
60.77
Rel Volume
1.28
Avg Volume
55.42K
Volume
71.12K
Perf Week
5.56%
Perf Month
8.25%
Perf Quarter
1.07%
Perf Half Y
2.52%
-
-
-
-
Beta
-0.422
-
-
Volatility
7.35%, 6.18%
Prev Close
-1.14%
Price
278.2
Change
-2.32%
CHEMCON.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 82.63 | 71.32 | 71.07 | 70.09 | 82.69 | |
| Net income per share | 11.75 | 13.34 | 16.48 | 17.13 | 15.04 | |
| Operating cash flow per share | 3.02 | 2.87 | 19 | 20.26 | 3.48 | |
| Free cash flow per share | -0.88 | -1.65 | 9.69 | 6.59 | -9.13 | |
| Cash per share | 0.19 | 0.29 | 14.96 | 30.7 | 36.9 | |
| Book value per share | 26.49 | 39.96 | 103.35 | 113.89 | 124.86 | |
| Tangible book value per share | 26.48 | 39.95 | 103.34 | 113.88 | 124.85 | |
| Share holders equity per share | 26.49 | 39.96 | 103.35 | 113.89 | 124.86 | |
| Interest debt per share | 9.82 | 13.41 | 2.85 | 9.98 | 17.88 | |
| Market cap | 21.42B | 21.42B | 13.95B | 9.77B | 8.38B | |
| Enterprise value | 21.75B | 21.87B | 13.77B | 9.77B | 8.58B | |
| P/E ratio | 49.77 | 43.85 | 24.73 | 15.56 | 15.21 | |
| Price to sales ratio | 7.08 | 8.2 | 5.73 | 3.8 | 2.77 | |
| POCF ratio | 193.72 | 203.98 | 21.45 | 13.16 | 65.77 | |
| PFCF ratio | -666.3 | -353.49 | 42.05 | 40.47 | -25.05 | |
| P/B Ratio | 22.08 | 14.64 | 3.94 | 2.34 | 1.83 | |
| PTB ratio | 22.08 | 14.64 | 3.94 | 2.34 | 1.83 | |
| EV to sales | 7.18 | 8.37 | 5.66 | 3.81 | 2.83 | |
| Enterprise value over EBITDA | 32.47 | 29.84 | 15.95 | 10.67 | 10.21 | |
| EV to operating cash flow | 196.65 | 208.23 | 21.17 | 13.16 | 67.31 | |
| EV to free cash flow | -676.39 | -360.86 | 41.5 | 40.48 | -25.64 | |
| Earnings yield | 0.02 | 0.02 | 0.04 | 0.06 | 0.07 | |
| Free cash flow yield | 0 | 0 | 0.02 | 0.02 | -0.04 | |
| Debt to equity | 0.34 | 0.31 | 0.02 | 0.09 | 0.14 | |
| Debt to assets | 0.19 | 0.2 | 0.02 | 0.07 | 0.12 | |
| Net debt to EBITDA | 0.48 | 0.61 | -0.21 | 0 | 0.23 | |
| Current ratio | 1.86 | 2.8 | 6.3 | 4.84 | 3.41 | |
| Interest coverage | 22.08 | 19.5 | 21.4 | 140.85 | 41.88 | |
| Income quality | 0.18 | 0.16 | 0.86 | 0.88 | 0.17 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0.02 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0.27 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.29 | -1.58 | -0.49 | -0.67 | -3.63 | |
| Capex to revenue | -0.05 | -0.06 | -0.13 | -0.2 | -0.15 | |
| Capex to depreciation | -4.98 | -3.59 | -5.24 | -7.99 | -5.52 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 83.68 | 109.5 | 195.75 | 209.52 | 205.58 | |
| ROIC | 0.34 | 0.26 | 0.16 | 0.13 | 0.09 | |
| Return on tangible assets | 0.25 | 0.22 | 0.14 | 0.13 | 0.1 | |
| Graham Net | 2.75 | 9.68 | 46.25 | 60.12 | 36.37 | |
| Working capital | 604.79M | 1.11B | 2.39B | 2.98B | 2.2B | |
| Tangible asset value | 970.04M | 1.46B | 3.54B | 4.17B | 4.57B | |
| Net current asset value | 550.88M | 931.38M | 2.35B | 2.95B | 2.15B | |
| Invested capital | 0.34 | 0.31 | 0.02 | 0.09 | 0.14 | |
| Average receivables | 633.77M | 1.01B | 1.45B | 1.99B | 1.51B | |
| Average payables | 230.75M | 272.97M | 241.54M | 232.3M | 226.25M | |
| Average inventory | 334.75M | 469.95M | 535.23M | 467.97M | 568.34M | |
| Days sales outstanding | 100.38 | 167.22 | 255.1 | 324.61 | 87.65 | |
| Days payables outstanding | 51.3 | 56.17 | 61.34 | 62.39 | 44.39 | |
| Days of inventory on hand | 81.58 | 104.99 | 160.16 | 90.49 | 164.17 | |
| Receivables turnover | 3.64 | 2.18 | 1.43 | 1.12 | 4.16 | |
| Payables turnover | 7.12 | 6.5 | 5.95 | 5.85 | 8.22 | |
| Inventory turnover | 4.47 | 3.48 | 2.28 | 4.03 | 2.22 | |
| ROE | 0.44 | 0.33 | 0.16 | 0.15 | 0.12 | |
| Capex per share | -3.9 | -4.52 | -9.31 | -13.67 | -12.61 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 15.84 | 20.87 | 21.54 | 21.62 | 20.51 | |
| Net income per share | 2.14 | 3.1 | 2.85 | 1.61 | 1.62 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 55.33 | 0 | 36.82 | 0 | 39.08 | |
| Book value per share | 119.18 | 0 | 124.59 | 0 | 127.98 | |
| Tangible book value per share | 119.17 | 0 | 124.59 | 0 | 127.98 | |
| Share holders equity per share | 119.18 | 0 | 124.59 | 0 | 127.98 | |
| Interest debt per share | 10.34 | 0.16 | 17.57 | 0.18 | 10.93 | |
| Market cap | 16.43B | 10.95B | 8.4B | 10.19B | 10.32B | |
| Enterprise value | 16.59B | 10.95B | 8.59B | 10.19B | 10.7B | |
| P/E ratio | 52.51 | 24.1 | 20.05 | 43.12 | 43.44 | |
| Price to sales ratio | 28.37 | 14.32 | 10.62 | 12.85 | 13.72 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 3.77 | 0 | 1.84 | 0 | 2.2 | |
| PTB ratio | 3.77 | 0 | 1.84 | 0 | 2.2 | |
| EV to sales | 28.64 | 14.32 | 10.87 | 12.85 | 14.23 | |
| Enterprise value over EBITDA | 128.83 | 61.02 | 50.7 | 90.18 | 94.18 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.09 | 0 | 0.14 | 0 | 0.08 | |
| Debt to assets | 0.07 | 0 | 0.12 | 0 | 0.07 | |
| Net debt to EBITDA | 1.21 | 0 | 1.15 | 0 | 3.34 | |
| Current ratio | 5.35 | 0 | 3.41 | 0 | 5.01 | |
| Interest coverage | 43.91 | 26.83 | 30.09 | 7.52 | 12.08 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 75.75 | 0 | 89.42 | 0 | 68.3 | |
| ROIC | 0.02 | 0 | 0.02 | 0 | 0.01 | |
| Return on tangible assets | 0.02 | 0 | 0.02 | 0 | 0.01 | |
| Graham Net | 61.99 | 0 | 36.29 | 0 | 49.27 | |
| Working capital | 2.97B | 1.94B | 2.2B | 1.31B | 2.7B | |
| Tangible asset value | 4.36B | 0 | 4.57B | 0 | 4.69B | |
| Net current asset value | 2.93B | 1.94B | 2.15B | 1.31B | 2.66B | |
| Invested capital | 0.09 | 0 | 0.14 | 0 | 0.08 | |
| Average receivables | 403.76M | 403.76M | 363.65M | 363.65M | 457.38M | |
| Average payables | 89.17M | 89.17M | 106.88M | 106.88M | 88.55M | |
| Average inventory | 354.31M | 354.31M | 395.23M | 395.23M | 406.55M | |
| Days sales outstanding | 125.48 | 0 | 82.77 | 0 | 109.49 | |
| Days payables outstanding | 45.87 | 0 | 35.9 | 0 | 29.82 | |
| Days of inventory on hand | 182.27 | 0 | 132.75 | 0 | 136.9 | |
| Receivables turnover | 0.72 | 0 | 1.09 | 0 | 0.82 | |
| Payables turnover | 1.96 | 0 | 2.51 | 0 | 3.02 | |
| Inventory turnover | 0.49 | 0 | 0.68 | 0 | 0.66 | |
| ROE | 0.02 | 0 | 0.02 | 0 | 0.01 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
CHEMCON.NS Frequently Asked Questions
What is Chemcon Speciality Chemicals Limited stock symbol ?
Chemcon Speciality Chemicals Limited is a IN stock and trading under the symbol CHEMCON.NS
What is Chemcon Speciality Chemicals Limited stock quote today ?
Chemcon Speciality Chemicals Limited stock price is $278.2 today.
Is Chemcon Speciality Chemicals Limited stock public?
Yes, Chemcon Speciality Chemicals Limited is a publicly traded company.
Company Profile
- Volume Average 55.42K
- Market Capitalization 10.19B
- Employee 204
- CEO Mr. Kamalkumar Rajendra Aggarwal
- Headquarters Vadodara,IN
- IPO Date 2020-10-01
-
Website
https://cscpl.com 
Chemcon Speciality Chemicals Limited engages in the manufacture and sale of pharmaceutical intermediates, silanes, and oilfield chemicals in India. It offers oilfield chemicals, including calcium bromide liquid, calcium bromide powder, sodium bromide solution, and zinc bromide solution; pharmaceutical chemicals, such as hexamethyl disilazane, chloromethyl isopropyl carbonate, trimethyl chlorosilane, and hexamethyl disiloxane; and Silanes comprising hexamethyl disilazane, trimethyl chlorosilane, and hexamethyl disiloxane, as well as provides contract manufacturing services. The company also exports its products to United States, Italy, South Korea, Germany, the People's Republic of China, Japan, the United Arab Emirates, Serbia, Russia, Spain, Thailand, and Malaysia. The company was incorporated in 1988 and is based in Vadodara, India.
